Characteristics and management of children with Clostridiodes difficile infection at a tertiary pediatric hospital in China

Characteristics and management of children with Clostridiodes difficile infection at a tertiary pediatric hospital in China

Background: Clostridiodes difficile infection (CDI) is one of the most common causes of antibiotic-associated diarrhea in children. Conventional antibiotics and emerging fecal microbiota transplantation (FMT) are used to treat CDI. Methods: Children with CDI admitted to the Shanghai Children's...

Full description

Bibliographic Details
Main Authors:	Hu, H. (Author), Li, D. (Author), Li, X. (Author), Li, Y. (Author), Wang, Y. (Author), Xiao, F. (Author), Xiao, Y. (Author), Xu, Q. (Author), Yu, G. (Author), Zhang, T. (Author)
Format:	Article
Language:	English
Published:	Elsevier Editora Ltda 2022
Subjects:	Antibiotic Children Clostridiodes difficile infection Fecal microbiota transplantation Vancomycin
Online Access:	View Fulltext in Publisher

Similar Items

Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by <i>Clostridiodes difficile</i>
by: Pedro Sánchez-Pellicer, et al.
Published: (2021-08-01)

Risk for Clostridiodes difficile Infection among Older Adults with Cancer
by: Mini Kamboj, et al.
Published: (2019-09-01)

The Association Between the Frequency of Interruptions in Antibiotic Exposure and the Risk of Health Care-Associated Clostridiodes difficile Infection
by: Jiyoun Song, MPhil, AGACNP-BC, RN, et al.
Published: (2020-01-01)

Successful Experience of Fecal Transplantation in a Patient with Severe Pseudomembranous Colitis
by: L. R. Shedoeva, et al.
Published: (2021-01-01)

Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan
by: Fu-Chieh Chang, et al.
Published: (2021-04-01)

Ocurrencia de Complicaciones en pacientes adultos con enfermedad inflamatoria intestinal e infección por Clostridiodes difficile: Una revisión sistemática
by: Sánchez Rojas, Ryan Joshua, et al.
Published: (2021)

Modern approach to the therapy of infections caused by Clostridium difficile
by: Jaćović Saša, et al.
Published: (2018-01-01)

Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020
by: Saraswathi Lakkasani, et al.
Published: (2020-09-01)

Management of Primary and Recurrent Clostridium difficile Infection: An Update
by: Jocelyn Chai, et al.
Published: (2018-06-01)

Fecal microbiota transplantation in refractory or recurrent Clostridium difficile infection: a real-life experience in a non-academic center
by: Ana Ponte, et al.

Initial experience with fecal microbiota transplantation in Clostridium difficile infection: transplant protocol and preliminary results
by: Ana Ponte, et al.
Published: (2015-07-01)

A Review of Management of Clostridium difficile Infection: Primary and Recurrence
by: Yasmeen Vincent, et al.
Published: (2015-09-01)

Clostridioides difficile infection: a comprehensive review for primary providers
by: Cortés Pedro, et al.
Published: (2021-09-01)

Prevention and treatment of Clostridium difficile infection
by: Gianenrico Rizzatti, et al.
Published: (2017-12-01)

Proteomic Signatures of <i>Clostridium difficile</i> Stressed with Metronidazole, Vancomycin, or Fidaxomicin
by: Sandra Maaß, et al.
Published: (2018-11-01)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
by: Shaaz Fareed, et al.
Published: (2018-05-01)

Reevaluating fecal microbiota transplantation for recurrent clostridium difficile infection
by: Hamilton, Mariah
Published: (2018)

Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation
by: Kai Markus Schneider, et al.
Published: (2018-02-01)

Commentary: Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome
by: Blessing O. Anonye, et al.
Published: (2018-04-01)

Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
by: Caroline Vincent, et al.
Published: (2015-07-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

Next Generation Fecal Microbiota Transplantation
by: Tae-Geun Gweon, et al.
Published: (2021-03-01)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
by: Kelsey E Huus, et al.
Published: (2021-01-01)

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
by: Massimo Sartelli, et al.
Published: (2019-02-01)

Guidelines for Clostridium difficile infection in adults
by: Michał Kukla, et al.
Published: (2020-03-01)

Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?
by: Krishna Vedala, et al.
Published: (2021-06-01)

Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection
by: Xiaolu Li, et al.
Published: (2018-11-01)

Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease
by: Sahil Khanna, et al.
Published: (2017-05-01)

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study
by: Amy Langdon, et al.
Published: (2021-02-01)

Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March–April 2020
by: Avnish Sandhu, et al.
Published: (2020-09-01)

Insights into the Role of Human Gut Microbiota in <i>Clostridioides difficile</i> Infection
by: Melina Kachrimanidou, et al.
Published: (2020-01-01)

Bacteriocins From LAB and Other Alternative Approaches for the Control of Clostridium and Clostridiodes Related Gastrointestinal Colitis
by: Svetoslav D. Todorov, et al.
Published: (2020-09-01)

Fecal Microbiota Transplantation for Refractory and Recurrent Clostridium difficile Infection: A Case Series of Nine Patients
by: Byoung Wook Bang, et al.
Published: (2017-04-01)

Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of <i>Clostridioides difficile</i> Infection: A Systematic Review and Meta-Analysis
by: Chia-Yu Chiu, et al.
Published: (2019-10-01)

Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent <i>Clostridioides difficile</i> Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis
by: Jae Hyun Shin, et al.
Published: (2019-07-01)

Refining the <i>Galleria mellonella</i> Model by Using Stress Marker Genes to Assess <i>Clostridioides difficile</i> Infection and Recuperation during Phage Therapy
by: Janet Y. Nale, et al.
Published: (2020-08-01)

Routine Treatment-Resistant Clostridium difficile Infection during Recovery from Myxedema
by: Jan K. Adamski, et al.
Published: (2017-11-01)

Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent <i>C. difficile</i> infections in a multi-center retrospective study
by: Marina Santiago, et al.
Published: (2019-01-01)

Detection of pathogens in blood or feces of adult horses with enteric disease and association with outcome of colitis
by: Jamie J. Kopper, et al.
Published: (2021-09-01)

Fecal microbiota transplantation in the treatment of Clostridium difficile infection: state of the art and literature review
by: BRUNO AMANTINI MESSIAS, et al.
Published: (2018-05-01)